Clinical application of SPECT/CT guided bone biopsy in patients with suspected bone metastases

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033934

Enrollment

Unknown

Registered

2020-06-17

Start date

2020-06-16

Completion date

Unknown

Last updated

2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:Biopsy pathology

Index test:SPECT/CT&#32

guided&#32

bone&#32

biopsy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Breast cancer patients with abnormal bone lesions found after SPECT / CT whole-body bone imaging and need further diagnosis by percutaneous pathology.

Exclusion criteria

Exclusion criteria: Patients with hemorrhagic tendency.

Design outcomes

Primary

Measure	Time frame
Total examination time;biopsy operation time;complications;CT radiation dose;pathological and immunohistochemical results;pathological and immunohistochemical results;	—

Countries

China

Contacts

Public ContactLi Xiaomin

Shanxi Bethune Hospital

15135103587@163.com+86 15135103587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026